[go: up one dir, main page]

WO2004091474A3 - Procedes de preparation de derives de la dhea - Google Patents

Procedes de preparation de derives de la dhea Download PDF

Info

Publication number
WO2004091474A3
WO2004091474A3 PCT/FR2004/000847 FR2004000847W WO2004091474A3 WO 2004091474 A3 WO2004091474 A3 WO 2004091474A3 FR 2004000847 W FR2004000847 W FR 2004000847W WO 2004091474 A3 WO2004091474 A3 WO 2004091474A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
methods
dhea
dhea derivatives
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2004/000847
Other languages
English (en)
Other versions
WO2004091474A2 (fr
Inventor
Marc Criton
Damien Gloux
Jean-Louis Montero
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratories Mayoly Spindler SAS
Original Assignee
Laboratories Mayoly Spindler SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratories Mayoly Spindler SAS filed Critical Laboratories Mayoly Spindler SAS
Priority to US10/552,336 priority Critical patent/US20070032462A1/en
Priority to EP04742438A priority patent/EP1631580A2/fr
Priority to JP2006505780A priority patent/JP2006522078A/ja
Publication of WO2004091474A2 publication Critical patent/WO2004091474A2/fr
Publication of WO2004091474A3 publication Critical patent/WO2004091474A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)

Abstract

Procédé de préparation de dérivés de la DHEA, tels que la 7-oxo-DHEA et la 7-hydroxy-DHEA, à partir de la DHEA elle-même.
PCT/FR2004/000847 2003-04-07 2004-04-06 Procedes de preparation de derives de la dhea Ceased WO2004091474A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US10/552,336 US20070032462A1 (en) 2003-04-07 2004-04-06 Novel methods for the preparation of dhea derivatives
EP04742438A EP1631580A2 (fr) 2003-04-07 2004-04-06 Procedes de preparation de derives de la dhea
JP2006505780A JP2006522078A (ja) 2003-04-07 2004-04-06 Ｄｈｅａ誘導体の製造方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0304282A FR2853318A1 (fr) 2003-04-07 2003-04-07 Nouveaux procedes de preparation de derives de la dhea
FR0304282 2003-04-07

Publications (2)

Publication Number Publication Date
WO2004091474A2 WO2004091474A2 (fr) 2004-10-28
WO2004091474A3 true WO2004091474A3 (fr) 2004-12-16

Family

ID=32982279

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2004/000847 Ceased WO2004091474A2 (fr) 2003-04-07 2004-04-06 Procedes de preparation de derives de la dhea

Country Status (5)

Country Link
US (1) US20070032462A1 (fr)
EP (1) EP1631580A2 (fr)
JP (1) JP2006522078A (fr)
FR (1) FR2853318A1 (fr)
WO (1) WO2004091474A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014172706A1 (fr) * 2013-04-19 2014-10-23 University Of Houston System Formulations de dhea co-cristallines
CN106632220A (zh) * 2016-12-12 2017-05-10 荆楚理工学院 一种伏立诺他中间体辛二酸酐的制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0555845A2 (fr) * 1992-02-14 1993-08-18 Mitsubishi Kasei Corporation Dérivés de stéroides
WO1997010255A1 (fr) * 1995-09-12 1997-03-20 Estee Lauder, Inc. Utilisation de nouveaux esters steroides agissant contre les affections de la peau
WO2001072767A1 (fr) * 2000-03-27 2001-10-04 L'oreal Derives de dehydroepiandrosterone, leur procede de preparation et leurs utilisations, notamment cosmetiques
WO2002064614A1 (fr) * 2001-02-14 2002-08-22 L'oreal Procedes de preparation de la 7alpha-hydroxy-dehydroepiandroster one
WO2003002124A1 (fr) * 2001-06-28 2003-01-09 Zhongshan University Utilisation de bis-acide(5-androsten-17-one-3$g(b)-hydroxyl)diesters pour la production de produits pharmaceutiques

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0555845A2 (fr) * 1992-02-14 1993-08-18 Mitsubishi Kasei Corporation Dérivés de stéroides
WO1997010255A1 (fr) * 1995-09-12 1997-03-20 Estee Lauder, Inc. Utilisation de nouveaux esters steroides agissant contre les affections de la peau
WO2001072767A1 (fr) * 2000-03-27 2001-10-04 L'oreal Derives de dehydroepiandrosterone, leur procede de preparation et leurs utilisations, notamment cosmetiques
WO2002064614A1 (fr) * 2001-02-14 2002-08-22 L'oreal Procedes de preparation de la 7alpha-hydroxy-dehydroepiandroster one
WO2003002124A1 (fr) * 2001-06-28 2003-01-09 Zhongshan University Utilisation de bis-acide(5-androsten-17-one-3$g(b)-hydroxyl)diesters pour la production de produits pharmaceutiques

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ADAMCZYK, MACIEJ ET AL: "Characterization of Protein-Hapten Conjugates. 1. Matrix-Assisted Laser Desorption Ionization Mass Spectrometry of Immuno BSA-Hapten Conjugates and Comparison with Other Characterization Methods", BIOCONJUGATE CHEMISTRY, 5(6), 631-5, 1994, XP002264108 *
LARDY, HENRY ET AL: "Ergosteroids II: biologically active metabolites and synthetic derivative of dehydroepiandrosterone", STEROIDS, 63(3), 158-165, 1998, XP002264107 *
PETTIT, GEORGE R. ET AL: "Steroids and related natural products. 104. Bufadienolides. 36. Synthesis of bufalitoxin and bufotoxin", JOURNAL OF ORGANIC CHEMISTRY, 52(16), 3573-8, 1987, XP002264109 *

Also Published As

Publication number Publication date
US20070032462A1 (en) 2007-02-08
JP2006522078A (ja) 2006-09-28
EP1631580A2 (fr) 2006-03-08
WO2004091474A2 (fr) 2004-10-28
FR2853318A1 (fr) 2004-10-08

Similar Documents

Publication Publication Date Title
EP1740156B8 (fr) Procede de production d'une forme galenique solide protegee contre un usage detourne
WO2004027822A3 (fr) Nanostructures orientees et procedes de preparation associes
WO2005047505A3 (fr) Techniques et produits d'expression de micro arn
WO2004110411A3 (fr) Comprime orodispersible multicouche
WO2009051460A3 (fr) Dérivés d'acide ascorbique couplés à un peptide
IL180893A0 (en) Method for the preparation of a d-erythro-2,2-difluoro-2-deoxy-1-oxoribose derivative
AU2003299284A1 (en) Method for the production of a semiconductor component
WO2005073152A3 (fr) Procede de production de polyisobutenylphenols
AU2003201163A1 (en) Method for the preparation of lariciresinol, cyclolariciresinol and secoisolariciresinol
WO2004011449A3 (fr) Procede de production de derives de phenylalanine
WO2004092481A3 (fr) Procede de traitement de surfaces de papier
AU2003294837A1 (en) Improved method for the production of vitamin b12
WO2006127368A3 (fr) Methodes pour synthetiser des imidazotriazinones
WO2004091474A3 (fr) Procedes de preparation de derives de la dhea
AU2003210435A1 (en) Method for the production of epoxidized polysulfides
AU2003258622A1 (en) Method for the production of $g(b)-carotinoids
WO2004065396A3 (fr) Esters d'acide phosphorique obtenus a partir de composes hydroxy aromatiques substitues par du polyisobutene
WO2007009887A3 (fr) Preparation contenant du sulfate de baryum
AU2003210379A1 (en) Method for the production of cyclohexanol from benzole
WO2007073937A3 (fr) Procede permettant de preparer des formes cristallines de l'orlistat
IL181339A0 (en) Method for the production of diarylcycloalkyl derivatives
WO2007057316A3 (fr) Nouveau procede de preparation de thoc
WO2004072024A3 (fr) Acide phosphonique de polyisobutylene et ses derives
AU2003271241A1 (en) Chitosan product, method for the production thereof, methods for producing chitosan product derivatives and compositions based thereon
AU2003267541A1 (en) Method for the production of substituted trifluoroethylenes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006505780

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2004742438

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004742438

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2007032462

Country of ref document: US

Ref document number: 10552336

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 10552336

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 2004742438

Country of ref document: EP